Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTN

24 Jun 2024
www.drugs.com
Clinical Result
MONDAY, June 24, 2024 -- For high-risk patients with hypertension, vigorous physical activity (VPA) may preserve cognitive function, according to a study published online June 6 in Alzheimer's & Dementia.
Richard Kazibwe, M.D., from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues categorized the baseline self-reported frequency of VPA into low and high (less than one and at least one session/week, respectively) and examined the association between VPA categories with incident mild cognitive impairment (MCI) and probable dementia events among individuals with high-risk hypertension.
The researchers found that low event rates per 1,000 person-years were seen for MCI (13.9 versus 19.7), probable dementia (6.3 versus 9.0), and MCI/probable dementia (18.5 versus 25.8) for participants in the high versus the low VPA category. High versus low VPA was associated with lower risk of MCI, probable dementia, and MCI/probable dementia in the multivariable Cox regression model (hazard ratios [95 percent confidence intervals], 0.81 [0.68 to 0.97], 0.80 [0.63 to 1.03], and 0.82 [0.70 to 0.96], respectively).
"We know that physical exercise offers many benefits, including lowering blood pressure, improving heart health, and potentially delaying cognitive decline," Kazibwe said in a statement. "However, the amount and the intensity of exercise needed to preserve cognition is unknown."
Abstract/Full Text (subscription or payment may be required)
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.